{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:33:39Z","timestamp":1792802019703,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["522004005"],"award-info":[{"award-number":["522004005"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["number522004005"],"award-info":[{"award-number":["number522004005"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ijid.2021.03.072","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T00:13:21Z","timestamp":1616804001000},"page":"237-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Invasive pneumococcal disease among adults with hematological and solid organ malignancies: A population-based cohort study"],"prefix":"10.1016","volume":"106","author":[{"given":"Hannah M.","family":"Garcia Garrido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam J.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarom","family":"Heijmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina M.","family":"van Sorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth A.M.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz-Josef","family":"Kl\u00fcmpen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Grobusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Goorhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijid.2021.03.072_bib0005","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/cid\/ciaa090","article-title":"Differences and temporal changes in risk of invasive pneumococcal disease in adults with hematological malignancies: results from a nationwide 16-year cohort study","volume":"73","author":"Andersen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2021.03.072_bib0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12879-016-1648-2","article-title":"Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors","volume":"16","author":"Backhaus","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2021.03.072_bib0015","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10096-019-03485-3","article-title":"Adult vaccination for pneumococcal disease: a comparison of the national guidelines in Europe","volume":"38","author":"Bonnave","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2021.03.072_bib0020","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"issue":"40","key":"10.1016\/j.ijid.2021.03.072_bib0025","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the advisory committee on immunization practices (ACIP)","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMR Morb Mortal Wkly Rep"},{"issue":"26","key":"10.1016\/j.ijid.2021.03.072_bib0030","doi-asserted-by":"crossref","first-page":"e1022","DOI":"10.1097\/MD.0000000000001022","article-title":"Effect of 23-valent pneumococcal polysaccharide vaccine inoculated during anti-cancer treatment period in elderly lung cancer patients on community-acquired pneumonia hospitalization: a nationwide population-based cohort study","volume":"94","author":"Chiou","year":"2015","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.ijid.2021.03.072_bib0035","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4143\/crt.2019.189","article-title":"2020. Immunogenicity and optimal timing of 13-valent pneumococcal conjugate vaccination during adjuvant chemotherapy in gastric and colorectal cancer: a randomized controlled trial","volume":"52","author":"Choi","year":"2020","journal-title":"Cancer Res Treat"},{"issue":"15","key":"10.1016\/j.ijid.2021.03.072_bib0040","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/j.vaccine.2010.01.025","article-title":"Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial","volume":"28","author":"Cordonnier","year":"2010","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.ijid.2021.03.072_bib0045","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1473-3099(18)30600-5","article-title":"Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Cordonnier","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"9785","key":"10.1016\/j.ijid.2021.03.072_bib0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(10)61493-6","article-title":"Post-splenectomy and hyposplenic states","volume":"378","author":"Di Sabatino","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ijid.2021.03.072_bib0055","first-page":"148","article-title":"Impact of rituximab (Rituxan) on the treatment of B-cell non-Hodgkin\u2019s lymphoma","volume":"35","author":"Dotan","year":"2010","journal-title":"P T"},{"key":"10.1016\/j.ijid.2021.03.072_bib0060","unstructured":"Dutch cancer registration (NKR) managed by the Comprehensive Netherlands Cancer Registration (IKNL). https:\/\/www.iknl.nl\/. [Accessed on 30 November 2020]."},{"key":"10.1016\/j.ijid.2021.03.072_bib0065","unstructured":"Dutch pharmacy perscription data, available online at https:\/\/www.gipdatabank.nl\/. [Accessed on 19 January 2021]."},{"issue":"1","key":"10.1016\/j.ijid.2021.03.072_bib0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/cid\/ciz728","article-title":"Incidence and risk factors for invasive pneumococcal disease and community-acquired pneumonia in human immunodeficiency virus-infected individuals in a high-income setting","volume":"71","author":"Garcia Garrido","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"84","key":"10.1016\/j.ijid.2021.03.072_bib0075","doi-asserted-by":"crossref","DOI":"10.3791\/51208-v","article-title":"Capsular serotyping of Streptococcus pneumoniae using the Quellung reaction","author":"Habib","year":"2014","journal-title":"J Vis Exp"},{"issue":"5","key":"10.1016\/j.ijid.2021.03.072_bib0080","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/thoraxjnl-2018-211767","article-title":"Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination","volume":"74","author":"Hanquet","year":"2019","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.ijid.2021.03.072_bib0085","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/cid\/cix739","article-title":"Trends in invasive pneumococcal disease in cancer patients after the introduction of 7-valent pneumococcal conjugate vaccine: a 20-year longitudinal study at a major urban cancer center","volume":"66","author":"Lee","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2021.03.072_bib0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/23744235.2015.1115894","article-title":"Invasive pneumococcal disease in patients with haematological malignancies before routine use of conjugate vaccines in Finland","volume":"48","author":"Lindstr\u00f6m","year":"2016","journal-title":"Infect Dis (Lond)"},{"issue":"31","key":"10.1016\/j.ijid.2021.03.072_bib0095","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1016\/j.vaccine.2015.06.012","article-title":"Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency","volume":"33","author":"Loubet","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.ijid.2021.03.072_bib0100","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1016\/S1473-3099(18)30601-7","article-title":"Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Mikulska","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.ijid.2021.03.072_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114966","article-title":"Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients\u2014preliminary report","volume":"9","author":"Pasiarski","year":"2014","journal-title":"PLoS One"},{"issue":"9700","key":"10.1016\/j.ijid.2021.03.072_bib0110","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(09)61114-4","article-title":"Pathogenesis, treatment, and prevention of pneumococcal pneumonia","volume":"374","author":"van der Poll","year":"2009","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ijid.2021.03.072_bib0115","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1002\/cam4.2253","article-title":"Response to pneumococcal vaccination in multiple myeloma","volume":"8","author":"Renaud","year":"2019","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.ijid.2021.03.072_bib0120","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbmt.2019.10.006","article-title":"Clinical effectiveness of conjugate pneumococcal vaccination in hematopoietic stem cell transplantation recipients","volume":"26","author":"Roberts","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"August (8)","key":"10.1016\/j.ijid.2021.03.072_bib0125","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.clinthera.2010.06.016","article-title":"Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged \u226565 years in the Netherlands","volume":"32","author":"Rozenbaum","year":"2010","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.ijid.2021.03.072_bib0130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1016\/j.ijid.2021.03.072_bib0135","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/S0959-8049(03)00622-1","article-title":"Trends in incidence of and mortality from cancer in The Netherlands in the period 1989-1998","volume":"39","author":"Siesling","year":"2003","journal-title":"Eur J Cancer"},{"issue":"19","key":"10.1016\/j.ijid.2021.03.072_bib0140","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood-2015-04-639203","article-title":"Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib","volume":"126","author":"Sun","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ijid.2021.03.072_bib0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1473-3099(17)30049-X","article-title":"Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study","volume":"17","author":"Suzuki","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"42","key":"10.1016\/j.ijid.2021.03.072_bib0150","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1016\/j.vaccine.2019.08.048","article-title":"Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults","volume":"37","author":"Thompson","year":"2019","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ijid.2021.03.072_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192640","article-title":"Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands","volume":"13","author":"Thorrington","year":"2018","journal-title":"PLoS One"},{"issue":"43","key":"10.1016\/j.ijid.2021.03.072_bib0160","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1016\/j.vaccine.2019.08.025","article-title":"Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease","volume":"37","author":"Vestjens","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ijid.2021.03.072_bib0165","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/21645515.2019.1632683","article-title":"Uptake of 13-valent pneumococcal conjugate vaccine among US adults aged 19 to 64 years with immunocompromising conditions","volume":"16","author":"Vietri","year":"2020","journal-title":"Hum Vaccin Immun"},{"issue":"12","key":"10.1016\/j.ijid.2021.03.072_bib0170","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1017\/S0950268810000919","article-title":"Increased risk of invasive pneumococcal disease in haematological and solid-organ malignancies","volume":"138","author":"Wong","year":"2010","journal-title":"Epidemiol Infect"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221002903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221002903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:18:33Z","timestamp":1777609113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221002903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":34,"alternative-id":["S1201971221002903"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.03.072","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive pneumococcal disease among adults with hematological and solid organ malignancies: A population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.03.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}